Form 4: MetLife Director Jeh C. Johnson Acquires Shares Under Deferred Compensation Plan
SEC Form 4 Filing
Director Jeh C. Johnson acquired 535 shares of MetLife common stock at $81.78 per share on October 1, 2024, through the company's deferred compensation plan.
Summary
- On October 1, 2024, Jeh C. Johnson, a director of MetLife, Inc., acquired 535 shares of common stock at a price of $81.78 per share.
- This transaction was part of MetLife's non-management director compensation arrangements, where a portion of retainer fees is paid in company stock.
- Johnson elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
- Following the reported transaction, Johnson beneficially owns 5,036 shares of MetLife common stock.
- A power of attorney was executed on September 24, 2024, authorizing Timothy J. Ring, Taylor Jansen, Morgan Mayes, and Jennifer Wang to file Section 16 reports on Johnson's behalf.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reflects a routine transaction related to director compensation. It's neither overwhelmingly positive nor negative.
Positives
- The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
Director share acquisitions are common and often tied to compensation plans. This transaction reflects standard practices for director compensation in publicly traded companies.
Comparison to Industry Standards
- Director compensation packages often include stock options or grants to align their interests with shareholders, similar to practices at companies like Prudential Financial and AIG.
- Deferred compensation plans are a common tool used by companies such as Goldman Sachs and JP Morgan Chase to attract and retain top talent, including non-management directors.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| September 24, 2024 | Date of the Limited Power of Attorney execution. |
| October 01, 2024 | Date of the transaction where common stock was acquired. |
| October 03, 2024 | Date of the signature on the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.